Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.03B | $1.08B | $1.05B | $1.24B | $1.16B | $1.28B | $1.25B | $1.30B | $1.27B | $1.35B |
| Revenue growth | — | 5.3% | -2.4% | 17.7% | -6.4% | 10.3% | -2.1% | 3.7% | -2.0% | 5.9% |
| Gross profit | $917M | $962M | $927M | $1.08B | $1.02B | $1.15B | $1.11B | $1.15B | $1.13B | $1.19B |
| Gross margin | 89.4% | 89.0% | 87.9% | 87.0% | 87.4% | 89.9% | 88.7% | 88.3% | 89.0% | 88.1% |
| Operating income | $232M | $247M | $184M | $257M | $219M | $344M | $207M | $216M | $258M | $265M |
| Operating margin | 22.6% | 22.9% | 17.4% | 20.7% | 18.8% | 26.9% | 16.5% | 16.6% | 20.3% | 19.6% |
| Net income | $186M | $206M | $41.7M | $255M | $231M | $310M | $184M | $201M | $262M | $255M |
| Net margin | 18.1% | 19.1% | 4.0% | 20.5% | 19.9% | 24.2% | 14.7% | 15.4% | 20.6% | 18.9% |
| EPS (diluted) | $1.81 | $2.00 | $0.39 | $2.44 | $2.25 | $2.97 | $1.81 | $2.05 | $2.69 | $2.62 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $360M | $378M | $352M | $328M | $344M | $448M | $319M | $367M | $327M | $472M |
| Capital expenditures | $101M | $99.6M | $72.8M | $96.3M | $66.3M | $54.5M | $47.9M | $30.3M | $30.0M | $36.3M |
| Free cash flow | $259M | $278M | $279M | $231M | $278M | $393M | $271M | $337M | $297M | $436M |
| Share buybacks | $101M | $100M | $150M | $341M | $174M | $246M | $530M | $149M | $160M | $125M |
| Dividends paid | $48.4M | $57.1M | $66.2M | $77.5M | $88.6M | $89.2M | $100M | $103M | $115M | $127M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $520M | $634M | $918M | $797M | $1.07B | $1.23B | $620M | $745M | $482M | $702M |
| Total assets | $2.31B | $2.53B | $2.87B | $2.82B | $2.92B | $3.11B | $2.69B | $2.98B | $3.11B | $3.23B |
| Total liabilities | $331M | $390M | $495M | $509M | $479M | $501M | $439M | $608M | $623M | $596M |
| Shareholders' equity | $1.97B | $2.14B | $2.36B | $2.31B | $2.43B | $2.60B | $2.25B | $2.36B | $2.48B | $2.62B |
| Retained earnings | $1.94B | $2.08B | $2.31B | $2.33B | $2.44B | $2.61B | $2.30B | $2.39B | $2.50B | $2.63B |
| Shares (wtd avg diluted) | 102M | 103M | 107M | 105M | 103M | 105M | 102M | 97.7M | 97.3M | 97.5M |
Every figure is extracted from Dolby Laboratories, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.